Table 2.
Features | |
---|---|
Age, years (SD) | 33.5 (9.6) |
Gender, % women | 75 |
Ethnicity, % | |
African American | 80 |
Caucasian | 20 |
Smoker, % | 5 |
Alcohol use, % | 5 |
Weight, kg (SD) | 65.4 (7.6) |
Died, % | 10 |
Intervals [years, mean (SD)] | |
Diagnosis duration (SLE-ESRD)* | 11.3 (10.9) |
Dialysis duration, years ESRD-transplant) | 3.4 (3.7) |
Time to recurrence (transplant-RLN)† | 4.5 (3.7) |
Follow up time (transplant-last visit) | 6.2 (4.1) |
Disease duration (SLE-last visit) | 14.1 (4.1) |
Serologic Features, Post Transplant [# positive/ total tested, (%)] | |
Anti-DNA antibodies | 3 / 13 (23) |
Anti-nuclear antibodies | 12 / 12 (100) |
Low complement | 6 / 15 (40) |
Systemic lupus erythematosus; end-stage renal disease
recurrent lupus nephritis.